NFKB1 and metabolic dysfunction-associated steatotic liver disease: FXR activation alleviates the progression of NAFLD through reduced lipogenesis and lipid absorption mediated by bile acids, increased FFA oxidation, affected cholesterol transportation, and inhibited NF-κB-mediated inflammatory signaling pathways (92).